Literature DB >> 8468225

Acquired arteriovenous fistula secondary to castration in a dog.

S W Aiken1, S Jakovljevic, G C Lantz, W E Blevins.   

Abstract

A 6-year-old castrated male Basset Hound was examined because of a 1-year history of a pulsating mass in the right inguinal region. The pulsatile mass was diagnosed as an arteriovenous fistula by physical examination and angiography. Surgical exploration revealed that the right testicular artery and vein, the artery of the ductus deferens, and the cremasteric artery were involved in the fistula. The fistula was believed to have developed secondary to castration performed at 6 months of age. The mass and associated vessels were completely excised and signs of recurrence were not observed 13 months after surgery.

Entities:  

Mesh:

Year:  1993        PMID: 8468225

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  Use of ethylene-vinyl alcohol copolymer as a liquid embolic agent to treat a peripheral arteriovenous malformation in a dog.

Authors:  William T N Culp; Craig B Glaiberman; Rachel E Pollard; Erik R Wisner
Journal:  J Am Vet Med Assoc       Date:  2014-07-15       Impact factor: 1.936

2.  Surgical correction of an arteriovenous fistula in a ring-tailed lemur (Lemur catta).

Authors:  Nancy C Boedeker; Philip Guzzetta; Steven L Rosenthal; Luis R Padilla; Suzan Murray; Kurt Newman
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

3.  Acquired arteriovenous fistula formation following cephalic vein intravenous catheterisation in a cat.

Authors:  Lisa Graziano; Stefania Di Paco; Giancarlo Avallone; Paola Roccabanca
Journal:  JFMS Open Rep       Date:  2019-02-26

4.  Dominant outflow vein occlusion in the management of naturally occurring peripheral arteriovenous anomalies in cats and dogs.

Authors:  Philip S Hyndman; Chick Weisse; Pamela Schwartz; Robert J Rosen
Journal:  J Vet Intern Med       Date:  2021-11-01       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.